T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVMN
1076
Evommune Inc
EVMN
$304M
| $25.8M | ﹤0.01% |
1,940,939
+821,918
| +73% | +$19.1M |
|
1077
Akamai
AKAM
$15.7B
| $25.4M | ﹤0.01% |
214,492
-1,147,239
| -84% | -$143M |
|
1078
Palomar
PLMR
$3.24B
| $25.2M | ﹤0.01% |
199,735
-60,586
| -23% | -$7.13M |
|
1079
Rush Street Interactive
RSI
$2.26B
| $25.1M | ﹤0.01% |
843,425
+747,761
| +782% | +$19.7M |
|
|
HAPN
1080
Happen Inc
HAPN
$1.72B
| $25M | ﹤0.01% |
1,205,353
+650,130
| +117% | +$11.1M |
|
1081
Kimco Realty
KIM
$15.1B
| $24.9M | ﹤0.01% |
982,578
-2,150,550
| -69% | -$51.6M |
|
|
KEEL
1082
Keel Infrastructure Corp
KEEL
$2.22B
| $24.8M | ﹤0.01% |
+4,319,581
| New | +$18.6M |
|
1083
New York Times
NYT
$10.3B
| $24.7M | ﹤0.01% |
353,616
-164,303
| -32% | -$12.7M |
|
|
AKTS
1084
Aktis Oncology
AKTS
$1.08B
| $24.6M | ﹤0.01% |
763,499
-800,697
| -51% | -$16.4M |
|
1085
Hudbay
HBM
$11.9B
| $24.5M | ﹤0.01% |
+1,038,750
| New | +$26.3M |
|
1086
Markel Group
MKL
$21.6B
| $24.4M | ﹤0.01% |
12,498
+743
| +6% | +$1.39M |
|
1087
Invitation Homes
INVH
$15.7B
| $24.4M | ﹤0.01% |
807,293
+1,003
| +0.1% | +$28.4K |
|
1088
Masco
MAS
$13.5B
| $24.3M | ﹤0.01% |
298,835
+163
| +0.1% | +$11.4K |
|
1089
Avalo Therapeutics
AVTX
$809M
| $24.2M | ﹤0.01% |
+1,311,715
| New | +$20.7M |
|
1090
Noble Corp
NE
$6.8B
| $24.2M | ﹤0.01% |
649,010
+105,535
| +19% | +$5.05M |
|
|
SF
1091
Stifel
SF
$10.6B
| $24.2M | ﹤0.01% |
346,463
-160,259
| -32% | -$11.9M |
|
1092
Generac Holdings
GNRC
$12.1B
| $24.2M | ﹤0.01% |
82,479
-350,636
| -81% | -$87.8M |
|
|
WCC
1093
WESCO International
WCC
$17.8B
| $24.1M | ﹤0.01% |
69,765
+17,252
| +33% | +$5.85M |
|
|
HAWK
1094
HawkEye 360 Inc
HAWK
$1.52B
| $24.1M | ﹤0.01% |
+1,191,282
| New | +$32.9M |
|
1095
AMN Healthcare
AMN
$1.33B
| $24.1M | ﹤0.01% |
743,550
+686,835
| +1,211% | +$17.7M |
|
1096
H.B. Fuller
FUL
$2.66B
| $24M | ﹤0.01% |
411,067
+343,006
| +504% | +$21.1M |
|
1097
Genuine Parts
GPC
$17.7B
| $23.9M | ﹤0.01% |
202,752
-470
| -0.2% | -$49.1K |
|
|
TLNCU
1098
Talon Capital Corp Units
TLNCU
| $23.9M | ﹤0.01% |
2,276,791
-1,331
| -0.1% | -$13.9K |
|
1099
Trimble
TRMB
$13.4B
| $23.8M | ﹤0.01% |
465,531
+81,947
| +21% | +$4.84M |
|
1100
Bunge Global
BG
$21B
| $23.8M | ﹤0.01% |
222,661
+10,596
| +5% | +$1.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.